Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Antidepressants and risk of cataract development
 
  • Details
Options

Antidepressants and risk of cataract development

Other Title
A population-based, nested case-control study
Journal
Journal of Affective Disorders
Date Issued
2017-06-01
Author(s)
MIN-YEN HSU  
DOI
10.1016/j.jad.2017.03.044
URI
https://www.scopus.com/pages/publications/85015934800
https://scholars.csmu.edu.tw/handle/123456789/27203
Abstract
Background Previous studies demonstrated increased risk of cataract development among users of selective serotonin reuptake inhibitors (SSRIs). However, it remains unknown whether this risk also prevails with the use of other types of antidepressants. The aim of this study was to investigate whether use of antidepressants is associated with an increased risk of cataract development. Moreover, the relationship between binding affinities of serotonin transporter (SERT) of antidepressant and the risk of cataracts is examined. Methods We conducted a nested case-control study using National Health Insurance Research Database in Taiwan. A total of 14,288 patients were included; 7651 in the cataract group and 6637 in the control group. Antidepressant exposure was categorized by type, duration of use, and binding affinities of SERT. The association between antidepressant exposure and cataract development was assessed using conditional logistic regression analysis. Results The adjusted odds ratios (AORs) for developing cataracts among continuous users of SSRIs, serotonin norepinephrine reuptake inhibitors (SNRIs), and other antidepressants were 1.26 (95% confidence interval (CI): 1.12–1.41, p<0.001), 1.21 (95% CI: 1.02–1.43, p=0.027), and 1.18 (95% CI: 1.04–1.34, p=0.009) respectively. Specifically, continuous uses of fluoxetine (AOR: 1.21; 95% CI: 1.01–1.46, p=0.042), fluvoxamine (AOR: 1.47; 95% CI: 1.01–2.12, p=0.043), venlafaxine (AOR: 1.44; 95% CI: 1.19–1.74, p<0.001) significantly increased the risk of cataract development. Moreover, continuous users of antidepressants with intermediate SERT binding affinities (AOR: 1.68; 95% CI: 1.10–2.56, p=0.017) were significantly associated with increased risks of cataract development. Limitations Several confounding factors such as obesity, multiple drug users, family history of cataracts, substance use, and environmental factors (such as sunlight or radiation exposure) were acquired. Conclusions We found increased risk of cataract development in patients continuously using antidepressants. Regular ocular evaluations in these patients are warranted.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback